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Method
We used two anaplastic, hormone-insensitive, fast-growing tumours (Dunning R-3327-AT1 H and E) and two well-differentiated, hormone-sensitive, slow-growing tumours (R-3327-H and R-3327-PAP). DNA-ploidy, Sphase transit time (Ts), the labelling index (LI) and potential doubling time (T pot) were determined by dual parameter¯ow cytometry, after in vivo labelling, using bromodeoxyuridine (BudR); the tumour doubling time (DT) was determined from growth curves.
Results
After castration, DT in the hormone-sensitive H subline changed from 21.7 to 82.0 days, and in the PAP subline from 22.2 to 33.2 days. No signi®cant changes in T pot were observed. In the anaplastic tumours no differences in either DT or T pot were observed. The cell loss factor (CLF) was relatively low in the two anaplastic tumours (0.55±0.59) compared with the well-differentiated tumours. The CLF was unaffected by castration in the poorly differentiated tumours, whereas it increased signi®cantly (from 0.75 to 0.92; P 0.005) after castration in the H tumour, and showed a non-signi®cant increase in the PAP tumour. This implies that the decrease in tumour growth in the hormone-sensitive tumours is due to an increase in cell death, not a decrease in cell proliferation.
Conclusion
These data indicate that CLF is the dominating factor in the reduced growth following androgen ablation in androgen-sensitive tumours. This study suggests that T pot might be an additional predictor of a tumour's proliferating rate and may provide important information on the human prostatic cancer.
